KLK3 and neoplasm: Patients with an aggressive disease showed higher total PSA levels (9 ng/mL vs. 7 ng/mL; p = 0.018) and lower PASE scores (93 vs. 104; p = 0.01) (Table 1) compared to those harboring a low-grade tumor.